18Oct
October 2016
Cabinet Barny advised Domain Therapeutics on the creation with Medicxi of Mavalon Therapeutics, a company focused on stopping the progression of Parkinson's disease.
Click here for more information.
Cabinet Barny advised Domain Therapeutics on the creation with Medicxi of Mavalon Therapeutics, a company focused on stopping the progression of Parkinson's disease.
Click here for more information.